|
Discussion:
SRWA asked "Where is HIV-1 drug resistance testing (RT) used predominantly" to determine if the representative knew where one of the newest HIV management tools was employed (Group_1 Slide). Since RT is recommended by a number of panels for first failure patients, it was expected that a significant number of representatives would respond in a similar manner. However, only 17% of responders said "First Failure." Instead, 69% of responders said RT was being used to manage "Salvage Therapy" patients only.
|
|
